20150121

Petfood Forum

Pet eNews
 Subscribe  
FDA sent a warning letter to a Nestle Purina PetCare manufacturing facility in Allentown, Pennsylvania, after an inspection in September 2014 revealed significant deviations from regulations.
Trouw Nutrition USA LLC
Oma’s Pride of Avon, Connecticut is recalling Purr-Complete Feline Poultry Meal because it has the potential to be contaminated with Salmonella.
Cargill Corn Milling North America
Despite recent slowdowns in petfood sales growth, US pet specialty retailers report increases for dog food, grain-free products and natural treats.
NuPulse
Online database of more than 350 petfood companies highlights mergers, acquisitions and other industry changes.
Extru-Tech Inc
Roughly 35,000 major US retailer stores are looking to stock FreshPet’s fresh petfood, according to company CEO Richard Thompson.
Wenger Manufacturing Co
Sussex, UK-based superpremium petfood company Arden Grange has received the "Best Dry Cat Food" award from the Your Dog and Your Cat Magazine awards 2014/2015, for the company’s adult fresh chicken and potato recipe.
Trouw Nutrition USA LLC
Sponsored Content
Whitepaper: Impact of fat coating procedure on palatability in cats
Discover how fat coating method impacts palatant availability and performance in cat kibbles.
Sponsored by SPF Diana

Whitepaper: Pet Food:  How it is Made
Pet owners demand high quality nutrient enriched foods for their pets.  Examine purchasing trends, ingredients and processing methods used in making pet foods.
Sponsored by Insta-Pro International

Register now for Petfood Forum and Save 15%!
Join us for the global Petfood industry’s primary conference and exhibit in Kansas City, Mo. USA, and save 15% with our Early Bird special until Feb. 15, 2015.
Sponsored by Petfood Industry magazine
 


 Reliance Mutual Fund
A sweet option that aims to give your portfolio a boost. Launching Reliance Capital Builder Fund II - Series B

Dear VIJAY HEMANTLAL PITHADIA,

We believe Indian economy has all the key ingredients of demographics, democracy, latent demand and entrepreneurial spirit to enable a strong growth over the next few years. With key triggers like improving macros, earnings growth, favorable non linear events we aim to remain optimistic on the equity markets.

With a view to capture these opportunities we are launching a Reliance Capital Builder Fund II – Series B a fund which attempts to provide twin benefits of Alpha generation through investments in Equity, active fund management and enhanced market participation through long call options. The scheme may also invest in Debt and Money Market Instruments up to 20%.

Note: The above fund philosophy may change in future depending on market conditions or fund manager’s views.
Warm Regards,


Sundeep Sikka
President & CEO,
Reliance Capital Asset Management Ltd
 
Contact your Financial AdvisorContact your
Financial Advisor
deviderARN NAME
Deliwala Bhikhalal Vadilal
deviderARN CODE
ARN-12672
Invest Online
Toll free 1800-300-11111http://www.reliancemutual.comcustomer_care@reliancemutual.com
 
Product Note, Online Updation of Contact detailsProduct NoteClick here for Dividend HistoryPresentationOther Scheme Performance and Product labelKIM cum Application Form
 
Online Updation of Contact detailsdeviderAccount Statement on EmaildeviderFeedback
 
Scheme Specific Risk Factors: Trading volumes and settlement periods may restrict liquidity in equity and debt investments. Investment in Debt is subject to price, credit, and interest rate risk. The NAV of the Scheme may be affected, inter alia, by changes in the market conditions, interest rates, trading volumes, settlement periods and transfer procedures. The NAV may also be subjected to risk associated with investment in derivatives, foreign securities or script lending as may be permissible by the Scheme Information Document.
Disclaimers
  • The information herein is meant only for general reading purposes and the views being expressed only constitute opinions and therefore cannot be considered as guidelines, recommendations or as a professional guide for the readers. Certain factual and statistical information (historical as well as projected) pertaining to Industry and markets have been obtained from independent third-party sources, which are deemed to be reliable. It may be noted that since RCAM has not independently verified the accuracy or authenticity of such information or data, or for that matter the reasonableness of the assumptions upon which such data and information has been processed or arrived at; RCAM does not in any manner assures the accuracy or authenticity of such data and information. Some of the statements & assertions contained in these materials may reflect RCAM’s views or opinions, which in turn may have been formed on the basis of such data or information.
  • Before making any investments, the readers are advised to seek independent professional advice, verify the contents in order to arrive at an informed investment decision. None of the Sponsor, the Investment Manager, the Trustee, their respective directors, employees, affiliates or representatives shall be liable in any way for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including on account of lost profits arising from the information contained in this material.
 
Product Label
  Reliance Capital Builder Fund II – Series B is suitable for investors who are seeking*:
. Long term capital growth
. Investment in diversified portfolio of equity & equity related instruments with small exposure to fixed income securities
. High risk. Brown BROWN
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
  Note: Risk is represented as:
 Blue(BLUE) investors understand that their principal will be at low riskYellow(YELLOW) investors understand that their principal will be at medium riskBrown(BROWN) investors understand that their principal will be at high risk
SMS charges apply.
 
DOWNLOAD THE APP TODAY! 
Google Play App Store
Connect with us:Facebook Youtube Twitter 
Mutual Fund investments are subject to market risks, read all scheme related documents carefully.